These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 315272

  • 1. Detection of breast tumor antigen-sensitive circulating T-lymphocytes by antigen-stimulated active rosette formation.
    Ramey WG, Hashim GA, Burrows WB, Swistel AJ, Munther A, Fitzpatrick HF.
    Cancer Res; 1979 Dec; 39(12):4796-801. PubMed ID: 315272
    [No Abstract] [Full Text] [Related]

  • 2. Detection of circulating lung tumor antigen-sensitive T lymphocytes in the early stages of lung cancer.
    Ramey WG, Hashim GA, Munther AS, Swistel AJ, Burrows WB, Fitzpatrick HF.
    Surgery; 1980 Aug; 88(2):202-7. PubMed ID: 6967233
    [No Abstract] [Full Text] [Related]

  • 3. [Cellular immunity in breast cancer patients].
    Spielmann M, Kitschke HJ, Tietje K.
    Onkologie; 1982 Aug; 5 Suppl():42-5. PubMed ID: 6752790
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of pre-existent immunity in patients with primary breast cancer: molecular and cellular assays to quantify antigen-specific T lymphocytes in peripheral blood mononuclear cells.
    Rentzsch C, Kayser S, Stumm S, Watermann I, Walter S, Stevanoviç S, Wallwiener D, Gückel B.
    Clin Cancer Res; 2003 Oct 01; 9(12):4376-86. PubMed ID: 14555509
    [Abstract] [Full Text] [Related]

  • 5. A comparison of the mechanism of T-cell depression following radiotherapy or surgery for stage III breast cancer.
    Shukla HS, Whitehead RH, Hughes LE.
    Clin Oncol; 1980 Mar 01; 6(1):39-47. PubMed ID: 6966205
    [No Abstract] [Full Text] [Related]

  • 6. [Circulating T cells in patients with breast or genital cancers in the pre-therapeutic phase].
    Strache RR, Büttner HH, Kunze M, Röpcke G.
    Zentralbl Gynakol; 1989 Mar 01; 111(12):816-23. PubMed ID: 2788342
    [Abstract] [Full Text] [Related]

  • 7. [Study of humoral and cellular immunity in the course of ovarian carcinoma].
    Laghi V, Carella G, Burrai I, Sacco F, Margariti PA, Villani L, Benedetti Panici P.
    Minerva Ginecol; 1979 Oct 10; 31(10):737-46. PubMed ID: 317512
    [No Abstract] [Full Text] [Related]

  • 8. Circulating breast tumour antigen-sensitive T lymphocytes in early breast cancer and high risk benign breast disease.
    Ramey WG, Hashim GA, Fitzpatrick HF.
    Br J Surg; 1979 Dec 10; 66(12):848-52. PubMed ID: 315807
    [Abstract] [Full Text] [Related]

  • 9. [Determination of active T lymphocytes in the peripheral blood by the AE rosette test. Correlation of the AE and E rosette tests with lymphocyte reactivity in vitro after PHA stimulation].
    Karwowska W, Kunicka A.
    Probl Med Wieku Rozwoj; 1982 Dec 10; 11():111-6. PubMed ID: 6983690
    [Abstract] [Full Text] [Related]

  • 10. A study of T-cell population in carcinoma breast.
    Nirwan PS, Ramdeo IN, Solanki RL.
    Indian J Cancer; 1980 Dec 10; 17(4):210-5. PubMed ID: 6262220
    [No Abstract] [Full Text] [Related]

  • 11. [Immunological profile of patients with neoplastic disease].
    Stivala F, Catania G, Basile F, Malaponte G, Bottiglieri C, Giovinetto A.
    Minerva Chir; 1981 Mar 15; 36(5):297-302. PubMed ID: 6972495
    [No Abstract] [Full Text] [Related]

  • 12. The kinetics of T lymphocyte subpopulations in guinea-pigs sensitized with allogeneic transplantation antigens.
    Hashim GA, Yee N, Ramey WG.
    Clin Exp Immunol; 1980 Sep 15; 41(3):533-40. PubMed ID: 6969158
    [Abstract] [Full Text] [Related]

  • 13. [Circulating immune complexes and immunologic reactivity in breast cancer].
    Bilynskiĭ BT, Loginskiĭ VE, Fetsich TG.
    Eksp Onkol; 1984 Sep 15; 6(3):50-2. PubMed ID: 6333978
    [Abstract] [Full Text] [Related]

  • 14. [Determination of TAA-binding cells in peripheral blood of breast cancer patients (author's transl)].
    Sauer H, Kraus I, Seliger C, Preusse C, Ambrosius H.
    Allerg Immunol (Leipz); 1980 Sep 15; 26(4):368-74. PubMed ID: 6452045
    [Abstract] [Full Text] [Related]

  • 15. [Active specific immunotherapy in patients with lung cancer following tumor removal].
    Mosienko MD, Dorfman MV, Romashko NI.
    Vopr Onkol; 1987 Sep 15; 33(3):31-6. PubMed ID: 3494337
    [Abstract] [Full Text] [Related]

  • 16. [Various immunological and immunomorphological changes in patients with breast cancer after interferon administration].
    Mkrtchian LN, Galstian AM, Ovanesbekova TG, Ter-Pogosian ZR, Kuznetsov VP.
    Vopr Onkol; 1986 Sep 15; 32(10):25-31. PubMed ID: 3490716
    [Abstract] [Full Text] [Related]

  • 17. Cell-mediated antitumor immunity in breast cancer patients evaluated by antigen-induced leukocyte adherence inhibition in test tubes.
    Grosser N, Thomson DM.
    Cancer Res; 1975 Sep 15; 35(9):2571-9. PubMed ID: 1097110
    [Abstract] [Full Text] [Related]

  • 18. [Initial immunologic evaluations in breast and thyroid cancer].
    Abeatici S, Mussa A, Levis P, Sandrucci S, Storta P.
    Minerva Med; 1982 Apr 28; 73(18):1149-54. PubMed ID: 6979010
    [Abstract] [Full Text] [Related]

  • 19. T and B lymphocytes in cancer patients.
    Sengupta U, Dutta TK, Gupta BD, Aikat BK.
    Indian J Cancer; 1978 Jun 28; 15(2):6-9. PubMed ID: 312245
    [No Abstract] [Full Text] [Related]

  • 20. [Immunological deficiencies associated with malignant gynecological tumors].
    Laurentaci G, Maiorino R, Schonauer S, Favoino B, Loiudice L.
    Minerva Ginecol; 1980 Apr 28; 32(4):303-7. PubMed ID: 6966773
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.